(VIANEWS) – Equus Total Return (EQS), Ellington Financial LLC (EFC), Catalyst Pharmaceuticals (CPRX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Equus Total Return (EQS)
139.2% sales growth and 7.5% return on equity
Equus Total Return, Inc. is a business development company (BDC) specializing in leveraged buyouts, management buyouts, corporate partnerships/joint ventures, growth and expansion capital, acquisition financing, roll-up acquisition strategies, operational turnarounds, recapitalizations of existing businesses, special situations, equity and equity-oriented securities issued by privately owned companies, debt securities including subordinate debt, debt convertible into common or preferred stock, or debt combined with warrants and common and preferred stock, and preferred equity financing. It invests in small to mid-sized companies and acts as a lead investor. It invests in technology, telecommunication, financial services, natural resource and industrial manufacturing and services. It invests in companies engaged in the alternative energy, real estate, healthcare, education, e-learning, leisure and entertainment, and foreign investment sector in the United States, China, India, and Europe. It investments include common and preferred stock, debt convertible into common or preferred stock, debt combined with warrants and options, and other rights to acquire common or preferred stock. It seeks to invest in companies between $1 million to $25 million with revenues between $5 million and $150 million with EBITDA between $2 million to $50 million. It seeks to take control and non-control equity positions. Equus Total Return, Inc. was founded in 1991 and is based in Houston, Texas with additional office in Vancouver, Canada.
Earnings Per Share
As for profitability, Equus Total Return has a trailing twelve months EPS of $0.22.
PE Ratio
Equus Total Return has a trailing twelve months price to earnings ratio of 6.73. Meaning, the purchaser of the share is investing $6.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.5%.
2. Ellington Financial LLC (EFC)
74.8% sales growth and 4.08% return on equity
Ellington Financial Inc., through its subsidiary, Ellington Financial Operating Partnership LLC, acquires and manages mortgage-related, consumer-related, corporate-related, and other financial assets in the United States. The company acquires and manages residential mortgage-backed securities (RMBS) backed by prime jumbo, Alt-A, manufactured housing, and subprime residential mortgage loans; RMBS for which the principal and interest payments are guaranteed by the U.S. government agency or the U.S. government-sponsored entity; residential mortgage loans; commercial mortgage-backed securities; commercial mortgage loans and other commercial real estate debt; and residential mortgage loans. It also provides collateralized loan obligations; mortgage-related and non-mortgage-related derivatives; equity investments in mortgage originators; and other strategic investments. In addition, the company offers consumer loans and asset-backed securities backed by consumer and commercial assets. Ellington Financial LLC was founded in 2007 and is based in Old Greenwich, Connecticut.
Earnings Per Share
As for profitability, Ellington Financial LLC has a trailing twelve months EPS of $0.46.
PE Ratio
Ellington Financial LLC has a trailing twelve months price to earnings ratio of 26.11. Meaning, the purchaser of the share is investing $26.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.08%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 29, 2023, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 15%.
Volume
Today’s last reported volume for Ellington Financial LLC is 910497 which is 24.25% above its average volume of 732740.
Moving Average
Ellington Financial LLC’s value is below its 50-day moving average of $12.80 and under its 200-day moving average of $12.93.
3. Catalyst Pharmaceuticals (CPRX)
70.9% sales growth and 37.49% return on equity
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $1.02.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 12.23. Meaning, the purchaser of the share is investing $12.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.49%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Catalyst Pharmaceuticals’s EBITDA is 23.29.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 5.97%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 120% and 118.2%, respectively.
4. Interactive Brokers Group (IBKR)
15.8% sales growth and 22.4% return on equity
Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in routing, executing, and processing trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.
Earnings Per Share
As for profitability, Interactive Brokers Group has a trailing twelve months EPS of $2.84.
PE Ratio
Interactive Brokers Group has a trailing twelve months price to earnings ratio of 28.15. Meaning, the purchaser of the share is investing $28.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.4%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 19.2% and 17%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 40%, now sitting on 4.24B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 29, 2023, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 0.5%.
Yearly Top and Bottom Value
Interactive Brokers Group’s stock is valued at $79.88 at 16:22 EST, way below its 52-week high of $95.59 and way higher than its 52-week low of $68.23.
5. Gentex Corporation (GNTX)
13.9% sales growth and 17.48% return on equity
Gentex Corporation designs, develops, manufactures, markets, and supplies digital vision, connected car, dimmable glass, and fire protection products in the United States, Germany, Japan, Mexico, and internationally. It operates through Automotive Products and Other segments. The company offers automotive products, including interior and exterior electrochromic automatic-dimming rearview mirrors, automotive electronics, and non-automatic-dimming rearview mirrors for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, automotive suppliers, and various aftermarket and accessory customers. It also provides variable dimmable windows to aircraft manufacturers and airline operators. In addition, the company offers photoelectric smoke detectors and alarms, electrochemical carbon monoxide alarms and detectors, audible and visual signaling alarms, and bells and speakers used in fire detection systems in office buildings, hotels, and other commercial and residential buildings, as well as researches and develops nanofiber chemical sensing products. The company sells its fire protection products directly, as well as through sales managers and manufacturer representative organizations to fire protection and security product distributors, electrical wholesale houses, and original equipment manufacturers of fire protection systems. Gentex Corporation was incorporated in 1974 and is headquartered in Zeeland, Michigan.
Earnings Per Share
As for profitability, Gentex Corporation has a trailing twelve months EPS of $1.56.
PE Ratio
Gentex Corporation has a trailing twelve months price to earnings ratio of 19.9. Meaning, the purchaser of the share is investing $19.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.48%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 4, 2023, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 1.55%.
Yearly Top and Bottom Value
Gentex Corporation’s stock is valued at $31.04 at 16:22 EST, under its 52-week high of $34.33 and way higher than its 52-week low of $23.76.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.9%, now sitting on 2.12B for the twelve trailing months.
